Publication date
January 2009
DOIAbstract
A subset (~3–5%) of patients with cystic fibrosis (CF) develops severe liver disease (CFLD) with portal hypertension
A subset (~3–5%) of patients with cystic fibrosis (CF) develops severe liver disease (CFLD) with portal hypertension
BACKGROUND: Polymorphisms in genes other than the cystic fibrosis transmembrane conductance regulato...
This thesis highlights two studies which seek to link phenotypic presentations in cystic fibrosis (C...
Cystic fibrosis-associated liver disease (CFLD) affects ca. 30 % of patients. The CFLD is now consid...
A subset (~3–5%) of patients with cystic fibrosis (CF) develops severe liver disease (CFLD) with por...
Context: A subset (approximate to 3%-5%) of patients with cystic fibrosis (CF) develops severe liver...
CONTEXT: A subset (approximately 3%-5%) of patients with cystic fibrosis (CF) develops severe liver ...
International audiencePURPOSE OF REVIEW: Cystic fibrosis (CF; OMIM 219700) is caused by variations i...
Liver disease is the third leading cause of death in patients with cystic fibrosis (CF), but feature...
Background: Cystic fibrosis is the most common lethal recessive disorder among Caucasians. Over 1500...
BACKGROUND: Cystic fibrosis is the most common lethal recessive disorder among Caucasians. Over 1500...
In many respects, genetic studies in cystic fibrosis (CF) serve as a paradigm for a human Mendelian ...
The identification of small molecules that target specific CFTR variants has ushered in a new era of...
Cystic Fibrosis (CF) is the most common monogenic disease among people of Western European descent a...
International audienceCystic fibrosis (CF)-related liver disease (CFLD) is a common symptom in patie...
Technological advances in genetics have made feasible and affordable large studies to identify genet...
BACKGROUND: Polymorphisms in genes other than the cystic fibrosis transmembrane conductance regulato...
This thesis highlights two studies which seek to link phenotypic presentations in cystic fibrosis (C...
Cystic fibrosis-associated liver disease (CFLD) affects ca. 30 % of patients. The CFLD is now consid...
A subset (~3–5%) of patients with cystic fibrosis (CF) develops severe liver disease (CFLD) with por...
Context: A subset (approximate to 3%-5%) of patients with cystic fibrosis (CF) develops severe liver...
CONTEXT: A subset (approximately 3%-5%) of patients with cystic fibrosis (CF) develops severe liver ...
International audiencePURPOSE OF REVIEW: Cystic fibrosis (CF; OMIM 219700) is caused by variations i...
Liver disease is the third leading cause of death in patients with cystic fibrosis (CF), but feature...
Background: Cystic fibrosis is the most common lethal recessive disorder among Caucasians. Over 1500...
BACKGROUND: Cystic fibrosis is the most common lethal recessive disorder among Caucasians. Over 1500...
In many respects, genetic studies in cystic fibrosis (CF) serve as a paradigm for a human Mendelian ...
The identification of small molecules that target specific CFTR variants has ushered in a new era of...
Cystic Fibrosis (CF) is the most common monogenic disease among people of Western European descent a...
International audienceCystic fibrosis (CF)-related liver disease (CFLD) is a common symptom in patie...
Technological advances in genetics have made feasible and affordable large studies to identify genet...
BACKGROUND: Polymorphisms in genes other than the cystic fibrosis transmembrane conductance regulato...
This thesis highlights two studies which seek to link phenotypic presentations in cystic fibrosis (C...
Cystic fibrosis-associated liver disease (CFLD) affects ca. 30 % of patients. The CFLD is now consid...
Add to ORKG